In a remarkable and unprecedented collaboration NEWMEDS (Novel Methods leading to NeW MEdications in Depression and Schizophrenia) have pooled resources to bring together data of 23,401 anonymized patients from 67 trials on 11 compounds in over 25 countries to form the single largest database of clinical trial data ever amassed in psychiatric research…
Home » Psychology news » International Collaboration Amasses Largest Database To Advance Drug Development In Depression And Schizophrenia
International Collaboration Amasses Largest Database To Advance Drug Development In Depression And Schizophrenia
November 11, 2010 by NewsBot


